Episode 186: Rebecca Robbins on Moderna v. NIH, plus psilocybin as a medicine
Nov 11, 2021•30 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Rebecca Robbins of the New York Times joins us to discuss the escalating tension between Moderna and the National Institutes of Health over just who invented a Covid-19 vaccine. Then, STAT's Olivia Goldhill calls in to explain Compass Pathways' promising results using psilocybin as a treatment for depression and the future of the nascent field of psychedelic medicines. We also discuss the latest news in the life sciences, including pills for Covid-19, the next FDA commissioner, and whether Pfizer CEO Albert Bourla listens to Joe Rogan.
For the best experience, listen in Metacast app for iOS or Android